Which has higher earnings and valuation, MDT or DXCM?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medtronic $36.36B 2.80 $4.80B $3.73 21.28 DexCom $4.66B 6.00 $836.30M $2.34 30.97

Is MDT or DXCM more profitable?

DexCom has a net margin of 19.31% compared to Medtronic's net margin of 13.20%. DexCom's return on equity of 33.33% beat Medtronic's return on equity. Company Net Margins Return on Equity Return on Assets Medtronic 13.20% 14.61% 7.80% DexCom 19.31% 33.33% 13.19%

Does the media refer more to MDT or DXCM?

In the previous week, Medtronic had 17 more articles in the media than DexCom. MarketBeat recorded 40 mentions for Medtronic and 23 mentions for DexCom. Medtronic's average media sentiment score of 1.23 beat DexCom's score of 1.14 indicating that Medtronic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 32 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive DexCom 17 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MDT or GEHC?

In the previous week, Medtronic had 27 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 40 mentions for Medtronic and 13 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.41 beat Medtronic's score of 1.23 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 32 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive GE HealthCare Technologies 12 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ISRG or MDT?

In the previous week, Intuitive Surgical had 27 more articles in the media than Medtronic. MarketBeat recorded 67 mentions for Intuitive Surgical and 40 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Intuitive Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 62 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive Medtronic 32 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to ABT or MDT?

In the previous week, Abbott Laboratories had 12 more articles in the media than Medtronic. MarketBeat recorded 52 mentions for Abbott Laboratories and 40 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 1.53 beat Medtronic's score of 1.23 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 47 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medtronic 32 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor BSX or MDT?

In the previous week, Boston Scientific had 7 more articles in the media than Medtronic. MarketBeat recorded 47 mentions for Boston Scientific and 40 mentions for Medtronic. Boston Scientific's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 43 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive Medtronic 32 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Medtronic (MDT) Competitors

$79.37 +0.03 (+0.03%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$79.40 +0.03 (+0.04%)

As of 06/18/2026 07:45 PM Eastern

Compare

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

Should you buy Medtronic stock or one of its competitors? MarketBeat compares Medtronic with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Medtronic include DexCom (DXCM), GE HealthCare Technologies (GEHC), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), and Boston Scientific (BSX). These companies are all part of the "medical" sector.

How does Medtronic compare to DexCom?

Medtronic (NYSE:MDT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

82.1% of Medtronic shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.3% of Medtronic shares are held by insiders. Comparatively, 0.3% of DexCom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Medtronic presently has a consensus target price of $99.00, suggesting a potential upside of 24.74%. DexCom has a consensus target price of $84.83, suggesting a potential upside of 17.06%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92

DexCom has a net margin of 19.31% compared to Medtronic's net margin of 13.20%. DexCom's return on equity of 33.33% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.61%	7.80%
DexCom	19.31%	33.33%	13.19%

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28
DexCom	$4.66B	6.00	$836.30M	$2.34	30.97

Medtronic has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market. Comparatively, DexCom has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

In the previous week, Medtronic had 17 more articles in the media than DexCom. MarketBeat recorded 40 mentions for Medtronic and 23 mentions for DexCom. Medtronic's average media sentiment score of 1.23 beat DexCom's score of 1.14 indicating that Medtronic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	32 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
DexCom	17 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DexCom beats Medtronic on 11 of the 17 factors compared between the two stocks.

How does Medtronic compare to GE HealthCare Technologies?

Medtronic (NYSE:MDT) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

Medtronic pays an annual dividend of $2.84 per share and has a dividend yield of 3.6%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Medtronic pays out 76.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Medtronic has increased its dividend for 49 consecutive years and GE HealthCare Technologies has increased its dividend for 1 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Medtronic had 27 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 40 mentions for Medtronic and 13 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.41 beat Medtronic's score of 1.23 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	32 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
GE HealthCare Technologies	12 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

Medtronic currently has a consensus target price of $99.00, indicating a potential upside of 24.74%. GE HealthCare Technologies has a consensus target price of $80.21, indicating a potential upside of 30.23%. Given GE HealthCare Technologies' higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

82.1% of Medtronic shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Medtronic has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28
GE HealthCare Technologies	$20.63B	1.36	$2.08B	$4.18	14.73

Medtronic has a net margin of 13.20% compared to GE HealthCare Technologies' net margin of 9.10%. GE HealthCare Technologies' return on equity of 20.46% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.61%	7.80%
GE HealthCare Technologies	9.10%	20.46%	5.73%

Summary

Medtronic beats GE HealthCare Technologies on 11 of the 18 factors compared between the two stocks.

How does Medtronic compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Medtronic has higher revenue and earnings than Intuitive Surgical. Medtronic is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	14.31	$2.86B	$8.25	49.31
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28

Intuitive Surgical has a net margin of 28.15% compared to Medtronic's net margin of 13.20%. Intuitive Surgical's return on equity of 15.98% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
Medtronic	13.20%	14.61%	7.80%

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Intuitive Surgical has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

In the previous week, Intuitive Surgical had 27 more articles in the media than Medtronic. MarketBeat recorded 67 mentions for Intuitive Surgical and 40 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	62 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medtronic	32 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Intuitive Surgical presently has a consensus price target of $573.42, indicating a potential upside of 40.96%. Medtronic has a consensus price target of $99.00, indicating a potential upside of 24.74%. Given Intuitive Surgical's stronger consensus rating and higher probable upside, equities analysts plainly believe Intuitive Surgical is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61

Summary

Intuitive Surgical beats Medtronic on 14 of the 16 factors compared between the two stocks.

How does Medtronic compare to Abbott Laboratories?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.8%. Medtronic pays an annual dividend of $2.84 per share and has a dividend yield of 3.6%. Abbott Laboratories pays out 70.6% of its earnings in the form of a dividend. Medtronic pays out 76.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 54 consecutive years and Medtronic has raised its dividend for 49 consecutive years.

Abbott Laboratories has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Abbott Laboratories has a net margin of 13.90% compared to Medtronic's net margin of 13.20%. Abbott Laboratories' return on equity of 17.62% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Medtronic	13.20%	14.61%	7.80%

Abbott Laboratories presently has a consensus target price of $118.30, indicating a potential upside of 33.71%. Medtronic has a consensus target price of $99.00, indicating a potential upside of 24.74%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, equities analysts clearly believe Abbott Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61

In the previous week, Abbott Laboratories had 12 more articles in the media than Medtronic. MarketBeat recorded 52 mentions for Abbott Laboratories and 40 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 1.53 beat Medtronic's score of 1.23 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	47 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medtronic	32 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$45.13B	3.41	$6.52B	$3.57	24.78
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28

Summary

Abbott Laboratories beats Medtronic on 17 of the 20 factors compared between the two stocks.

How does Medtronic compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

Boston Scientific has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

Boston Scientific currently has a consensus target price of $85.08, suggesting a potential upside of 87.81%. Medtronic has a consensus target price of $99.00, suggesting a potential upside of 24.74%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Boston Scientific is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61

Medtronic has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28

Boston Scientific has a net margin of 17.29% compared to Medtronic's net margin of 13.20%. Boston Scientific's return on equity of 19.17% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Medtronic	13.20%	14.61%	7.80%

In the previous week, Boston Scientific had 7 more articles in the media than Medtronic. MarketBeat recorded 47 mentions for Boston Scientific and 40 mentions for Medtronic. Boston Scientific's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	43 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive
Medtronic	32 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.3% of Boston Scientific shares are held by company insiders. Comparatively, 0.3% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Boston Scientific beats Medtronic on 12 of the 17 factors compared between the two stocks.

Get Medtronic News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDT vs. The Competition

Export

Metric	Medtronic	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$101.86B	$8.34B	$6.43B	$23.20B
Dividend Yield	3.58%	2.55%	2.68%	4.06%
P/E Ratio	21.28	15.57	24.75	31.61
Price / Sales	2.80	7.37	529.79	112.07
Price / Cash	10.11	17.05	45.07	24.44
Price / Book	2.11	3.28	10.80	4.68
Net Income	$4.80B	$224.06M	$3.57B	$1.08B
7 Day Performance	-0.93%	-1.92%	0.72%	-0.82%
1 Month Performance	1.60%	-2.90%	0.41%	1.07%
1 Year Performance	-8.03%	0.83%	29.34%	25.02%

Medtronic Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDT Medtronic	4.943 of 5 stars	$79.37 +0.0%	$99.00 +24.7%	-8.0%	$101.86B	$36.36B	21.28	95,000	Positive News Analyst Forecast
DXCM DexCom	4.5793 of 5 stars	$74.20 -1.5%	$84.83 +14.3%	-9.4%	$28.63B	$4.82B	31.71	11,000	Positive News Insider Trade
GEHC GE HealthCare Technologies	4.9354 of 5 stars	$64.67 -0.8%	$80.21 +24.0%	-13.6%	$29.42B	$20.98B	15.47	54,000	Positive News
ISRG Intuitive Surgical	4.3099 of 5 stars	$416.40 +1.3%	$571.28 +37.2%	-20.1%	$147.47B	$10.06B	50.47	17,021	Positive News
ABT Abbott Laboratories	4.9903 of 5 stars	$88.76 +0.7%	$118.38 +33.4%	-33.4%	$154.60B	$45.13B	24.86	115,000	Positive News Dividend Announcement Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MDT) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Summary

How does Medtronic compare to Intuitive Surgical?

Summary

How does Medtronic compare to Abbott Laboratories?

Summary

How does Medtronic compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Do insiders & institutionals hold more shares of MDT or DXCM?

Do analysts prefer MDT or DXCM?

Is MDT or DXCM more profitable?

Which has higher earnings and valuation, MDT or DXCM?

Which has more risk and volatility, MDT or DXCM?

Does the media refer more to MDT or DXCM?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Is MDT or GEHC a better dividend stock?

Does the media prefer MDT or GEHC?

Which has more volatility & risk, MDT or GEHC?

Do analysts rate MDT or GEHC?

Do institutionals and insiders believe in MDT or GEHC?

Which has stronger earnings & valuation, MDT or GEHC?

Is MDT or GEHC more profitable?

Summary

How does Medtronic compare to Intuitive Surgical?

Which has stronger earnings and valuation, ISRG or MDT?

Is ISRG or MDT more profitable?

Do insiders & institutionals believe in ISRG or MDT?

Which has more volatility and risk, ISRG or MDT?

Does the media favor ISRG or MDT?

Do analysts recommend ISRG or MDT?

Summary

How does Medtronic compare to Abbott Laboratories?

Is ABT or MDT a better dividend stock?

Which has more volatility and risk, ABT or MDT?

Do insiders & institutionals have more ownership in ABT or MDT?

Is ABT or MDT more profitable?

Do analysts rate ABT or MDT?

Does the media refer more to ABT or MDT?

Which has preferable valuation and earnings, ABT or MDT?

Summary

How does Medtronic compare to Boston Scientific?

Which has more risk & volatility, BSX or MDT?

Do analysts rate BSX or MDT?

Which has higher earnings & valuation, BSX or MDT?

Is BSX or MDT more profitable?

Does the media favor BSX or MDT?

Do insiders & institutionals have more ownership in BSX or MDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools